In Vitro Diagnostics News and Research

RSS

Lancaster researchers develop new blood-testing technology to improve healthcare treatments

New blood-testing technology that promises to improve healthcare treatments for cancer patients, post-operative care and monitor the health of babies in the womb is being developed by Lancaster academics.

10 Aug 2016

Bio-Rad expands product line by launching two human recombinant antigens

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced the launch of two human recombinant antigens, expanding the company's portfolio of Critical Raw Materials for the in vitro diagnostics market.

1 Aug 2016

Abingdon Health appoints JoyingBio as distributor of PCRD lateral flow immunoassays in China

Abingdon Health Ltd is pleased to announce the appointment of JoyingBio as distributor in China for PCRD nucleic acid lateral flow immunoassays (NALFIA).

30 Jul 2016

UK Export Award winner BBI Solutions to attend 2016 AACC

BBI Solutions, recent winners of the Made in the UK Export Award, will be attending the AACC Clinical Lab Expo in Philadelphia next month.

30 Jul 2016

New LPD Series dispense pump meets demands of modern day applications

After 20 years of experience designing and manufacturing dispense pumps for in vitro diagnostics and scientific instrument applications, The Lee Company is pleased to offer its most cost effective design yet.

30 Jul 2016

Web Industries announces opening of new LFI production facility

Web Industries, Inc., innovative provider of precision contract manufacturing and converting services, is proud to announce the opening of the company's first lateral flow immunoassay (LFI) production facility.

30 Jul 2016

Surmodics introduces advanced immunoassay stabilizer StabilBlock

Surmodics, Inc., the global leader in chemical components for in vitro diagnostic (IVD) tests and microarrays, today announced the launch and immediate availability of StabilBlock, its most advanced Immunoassay Stabilizer.

28 Jul 2016

Aelan's researchers develop novel epigenetic biomarker for diagnosis of AD

Aelan Cell Technologies today announced the development of a novel epigenetic biomarker. An early human clinical feasibility study has indicated that serological tests using the biomarker alongside other proprietary components developed by Aelan's researchers could potentially help physicians diagnose Alzheimer's disease (AD).

12 Jul 2016

Critical evaluation of EKF Diagnostics’ Quo-Test analyzer released

EKF, announces release of a significant critical evaluation of the Quo-Test analyzer carried out by the European Reference Laboratory for Gylcohemoglobin.

From EKF Diagnostics 11 Jul 2016

AMP looks forward to working with FDA to determine optimal approach to regulating NGS tests

The Association for Molecular Pathology, the premier global, non-profit organization serving molecular diagnostic professionals, today announced that it looks forward to working with the U.S. Food and Drug Administration to determine the best adaptive approach to regulating Next-Generation Sequencing (NGS) tests.

11 Jul 2016

FDA approves Roche cobas HPV Test to be used with SurePath Preservative Fluid

The U.S. Food and Drug Administration today approved the Roche cobas HPV Test as the first test for Human Papilloma Virus (HPV) that can be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid.

8 Jul 2016

Roche Diagnostics responds to HPV announcement

Roche Diagnostics welcomes the announcement by Public Health Minister, Jane Ellison, to introduce Human Papillomavirus (HPV) primary screening in England.

6 Jul 2016

Comprehensive NMR profiling module for detailed lipoprotein subclass analysis announced by Bruker (research use only)

At the 12th Annual Conference of the Metabolomics Society (www.metabolomics2016.org), Bruker announces a new, more comprehensive, more efficient and easy-to-use profiling module for detailed lipoprotein subclass analysis using Nuclear Magnetic Resonance (NMR).

From Bruker BioSpin - NMR, EPR and Imaging 1 Jul 2016

NMR-based metabolomics: an interview with Prof. Claudio Luchinat

Professor Claudio Luchinat, University of Florence and co-founder of the Magnetic Resonance Center (CERM), speaks to News-Medical about his research in NMR-based metabolomics.

From Bruker BioSpin - NMR, EPR and Imaging 9 Jun 2016

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.

2 Jun 2016

OGT launches Cytocell FISH probes for glial tumours

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.

4 May 2016

Renishaw inVia to support development of nanomolecular probes in Kircher Laboratory at Memorial Sloan Kettering

The Kircher laboratory at Memorial Sloan Kettering is developing novel nanoprobes for molecular imaging, image-guided therapy and theranostics.

4 Mar 2016

IL obtains 510(k) clearance for ACL TOP Family 50 Series Hemostasis Testing Systems

Instrumentation Laboratory today announced the 510(k) clearance of their latest innovation, the ACL TOP Family 50 Series Hemostasis Testing Systems, by the US Food and Drug Administration.

21 Dec 2015

WHO Prequalification of IVDs Programme accepts Beckman Coulter’s Aquios CL flow cytometer

Beckman Coulter Life Sciences announce that their Aquios CL flow cytometer has been accepted by the World Health Organization (WHO) Prequalification of In Vitro Diagnostics Programme. It can now be used specifically for the immunologic assessment of patients having, or suspected of having, immune deficiency.

7 Dec 2015

SkylineDx's MMprofiler receives CE-IVD certification

SkylineDx, today announced they have received CE-IVD registration from the European Competent Authority (Ministry of Health) for the MMprofiler, the company's prognostic test to determine the level of risk of a patient with multiple myeloma (MM).

25 Nov 2015